Repligen (RGEN) Stock Looks Fairly Valued As Cash Flow Growth Matters
Repligen has had a mixed run, with the share price at US$162.78 after several years of uneven returns. This puts fresh focus on whether the current market value lines up with the cash the business can generate over time. For anyone considering the stock today, the live question is how that cash flow story stacks up against the recent performance profile. Over the past 5 years, Repligen shares have fallen 40.6%, which puts longer term cash flow prospects under the microscope despite shorter...

What's Your Reaction?









